DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Colombo N, Gadducci A, Sehouli J. et al.
LBA30 INOVATYON study: Randomized phase III international study comparing trabectedin/PLD followed by platinum at progression vs. carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6–12 months after last platinum line.
Ann Oncol 2020;
DOI: 10.1016/j.annonc.2020.08.2260.
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.